Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients

americanpharmaceuticalreviewSeptember 27, 2020

Tag: Rigel , fostamatinib , COVID-19 , SYK

PharmaSources Customer Service